Skip to main content
Top
Published in: Current Atherosclerosis Reports 6/2010

01-11-2010

Dietary Monounsaturated Fatty Acids Appear Not to Provide Cardioprotection

Authors: Chiara Degirolamo, Lawrence L. Rudel

Published in: Current Atherosclerosis Reports | Issue 6/2010

Login to get access

Abstract

Dietary interventions have been consistently proposed as a part of a comprehensive strategy to lower the incidence and severity of coronary heart disease (CHD), in the process providing long-term cardioprotection. Replacement of dietary saturated fatty acids (SFA) with higher intakes of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) has been reported to be inversely associated with risk of CHD. The observed lower incidence of CHD among populations consuming a Mediterranean-type diet, mainly enriched in MUFA from olive oil, has long supported the belief that MUFA are an optimal substitution for SFA. However, both epidemiologic and interventional studies suggest that although substituting MUFA-rich foods for SFA-rich foods in the diet can potentially lower total plasma cholesterol concentrations, this substitution does not lower the extent of coronary artery atherosclerosis. In addition, although recent evidence suggests that the source of MUFA (animal fat vs vegetable oils) may differentially influence the correlation between MUFA intake and CHD mortality, animal studies suggest that neither source is cardioprotective.
Literature
1.
go back to reference Mente A, de Koning L, Shannon HS, Anand SS: A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169:659–669.CrossRefPubMed Mente A, de Koning L, Shannon HS, Anand SS: A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009, 169:659–669.CrossRefPubMed
2.
go back to reference Keys A: Coronary heart disease in seven countries. Circulation 1970, 41(Suppl1):1–211. Keys A: Coronary heart disease in seven countries. Circulation 1970, 41(Suppl1):1–211.
3.
go back to reference de Lorgeril M, Salen P: The Mediterranean diet: rationale and evidence for its benefits. Curr Atheroscl Rep 2008, 10:518–522.CrossRef de Lorgeril M, Salen P: The Mediterranean diet: rationale and evidence for its benefits. Curr Atheroscl Rep 2008, 10:518–522.CrossRef
4.
go back to reference Keys A, Anderson JT, Grande F: Prediction of serum-cholesterol responses of man to changes in fats in the diets. Lancet 1957, 2:960–966. Keys A, Anderson JT, Grande F: Prediction of serum-cholesterol responses of man to changes in fats in the diets. Lancet 1957, 2:960–966.
5.
go back to reference Hegsted DM, McGandy RB, Myers ML, Stare FJ: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965, 17:281–295.PubMed Hegsted DM, McGandy RB, Myers ML, Stare FJ: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965, 17:281–295.PubMed
6.
go back to reference Mattson FH, Grundy SM: Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985, 26:194–202.PubMed Mattson FH, Grundy SM: Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985, 26:194–202.PubMed
7.
go back to reference Grundy SM: Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986, 314:745–748.CrossRefPubMed Grundy SM: Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986, 314:745–748.CrossRefPubMed
8.
go back to reference Lloyd-Jones D, Adams RJ, Todd M, et al.: Heart Disease and Stroke Statistics 2010 Update: a report from the American Heart Association. Circulation 2010, 121:e46–e215.CrossRefPubMed Lloyd-Jones D, Adams RJ, Todd M, et al.: Heart Disease and Stroke Statistics 2010 Update: a report from the American Heart Association. Circulation 2010, 121:e46–e215.CrossRefPubMed
9.••
go back to reference Jakobsen MU, O’Reilly E, Heitmann BL, et al.: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425–1432. This large follow-up study provides powerful evidence that over a wide range of intakes, MUFA does not provide CHD prevention.CrossRefPubMed Jakobsen MU, O’Reilly E, Heitmann BL, et al.: Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425–1432. This large follow-up study provides powerful evidence that over a wide range of intakes, MUFA does not provide CHD prevention.CrossRefPubMed
10.••
go back to reference Warensjo E, Sundstrom J, Vessby B, et al: Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 2008, 88:203–209. This study showed for the first time that when coronary mortality is assessed over a period of 30 years, serum MUFA levels are positively associated with coronary deaths.PubMed Warensjo E, Sundstrom J, Vessby B, et al: Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 2008, 88:203–209. This study showed for the first time that when coronary mortality is assessed over a period of 30 years, serum MUFA levels are positively associated with coronary deaths.PubMed
11.
go back to reference Elmadfa I, Kornsteiner M: Dietary fat intake-a global perspective. Ann Nutr Metab 2009, 54(Suppl 1):8–14.CrossRefPubMed Elmadfa I, Kornsteiner M: Dietary fat intake-a global perspective. Ann Nutr Metab 2009, 54(Suppl 1):8–14.CrossRefPubMed
13.
go back to reference Ros E: Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003, 78(Suppl):617S–625S.PubMed Ros E: Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003, 78(Suppl):617S–625S.PubMed
14.
go back to reference Watts GF, Jackson P, Burke V, Lewis B: Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996, 64:202–209.PubMed Watts GF, Jackson P, Burke V, Lewis B: Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996, 64:202–209.PubMed
15.
go back to reference Brouwer IA, Wanders AJ, Katan MB: Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans—a quantitative review. PLoS ONE 2010, 5:e9434.CrossRefPubMed Brouwer IA, Wanders AJ, Katan MB: Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans—a quantitative review. PLoS ONE 2010, 5:e9434.CrossRefPubMed
16.
go back to reference Truswell AS, Choudhury N: Monounsaturated oils do not all have the same effect on plasma cholesterol. Eur J Clin Nutr 1998, 52:312–315.CrossRefPubMed Truswell AS, Choudhury N: Monounsaturated oils do not all have the same effect on plasma cholesterol. Eur J Clin Nutr 1998, 52:312–315.CrossRefPubMed
17.
go back to reference Mensink RP, de Groot MJM, van den Broeke LT, et al.: Effects of monounsaturated fatty acids vs. complex carbohydrates on serum lipoproteins and apoproteins in healthy men and women. Metabolism 1989, 38:172–178.CrossRefPubMed Mensink RP, de Groot MJM, van den Broeke LT, et al.: Effects of monounsaturated fatty acids vs. complex carbohydrates on serum lipoproteins and apoproteins in healthy men and women. Metabolism 1989, 38:172–178.CrossRefPubMed
18.
go back to reference Visioli F, Galli C: Antiatherogenic components of olive oil. Curr Atheroscl Rep 2001, 3:64–67.CrossRef Visioli F, Galli C: Antiatherogenic components of olive oil. Curr Atheroscl Rep 2001, 3:64–67.CrossRef
19.
go back to reference Ramirez-Tortosa MC, Urbano G, Lopez-Jurado M, et al.: Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr 1999, 129:2177–2183.PubMed Ramirez-Tortosa MC, Urbano G, Lopez-Jurado M, et al.: Extra-virgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr 1999, 129:2177–2183.PubMed
20.
go back to reference Bos MB, de Vries JH, Feskens EJ, et al.: Effect of a high monounsaturated fatty acid diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis 2009 Aug 17 [Epub ahead of print]. Bos MB, de Vries JH, Feskens EJ, et al.: Effect of a high monounsaturated fatty acid diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity. Nutr Metab Cardiovasc Dis 2009 Aug 17 [Epub ahead of print].
21.
go back to reference Green CD, Ozguden-Akkoc CG, Wang Y, et al.: Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. J Lipid Res 2010, 51:1871–1877.CrossRefPubMed Green CD, Ozguden-Akkoc CG, Wang Y, et al.: Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. J Lipid Res 2010, 51:1871–1877.CrossRefPubMed
22.
go back to reference Nestel P, Clifton P, Noakes M: Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 1994, 35:656–662.PubMed Nestel P, Clifton P, Noakes M: Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res 1994, 35:656–662.PubMed
23.
go back to reference Griel AE, Cao Y, Bagshaw DD, et al.: A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr 2008, 138:761–767.PubMed Griel AE, Cao Y, Bagshaw DD, et al.: A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr 2008, 138:761–767.PubMed
24.
go back to reference Garg ML, Blake RJ, Wills RB: Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr 2003, 133:1060–1063.PubMed Garg ML, Blake RJ, Wills RB: Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr 2003, 133:1060–1063.PubMed
25.
go back to reference Brown JM, Shelness GS, Rudel LL: Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep 2007, 9:494–500.CrossRefPubMed Brown JM, Shelness GS, Rudel LL: Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep 2007, 9:494–500.CrossRefPubMed
26.
go back to reference Mensink RP, Katan MB: Effects of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911–919.PubMed Mensink RP, Katan MB: Effects of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911–919.PubMed
27.
go back to reference Gardner CD, Kraemer HC: Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995, 15:1917–1927.PubMed Gardner CD, Kraemer HC: Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis. Arterioscler Thromb Vasc Biol 1995, 15:1917–1927.PubMed
28.
go back to reference Hu FB, Stampfer MJ, Manson JE, et al.: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491–1499.CrossRefPubMed Hu FB, Stampfer MJ, Manson JE, et al.: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491–1499.CrossRefPubMed
29.
go back to reference Lòpez-Miranda J, Pèrez-Jimènez F, Ros E, et al.: Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaèn and Còrdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010, 20:284–294.CrossRefPubMed Lòpez-Miranda J, Pèrez-Jimènez F, Ros E, et al.: Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaèn and Còrdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010, 20:284–294.CrossRefPubMed
30.
go back to reference Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al.: Diet and overall survival in elderly people. BMJ 1995, 311:1457–1460.PubMed Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al.: Diet and overall survival in elderly people. BMJ 1995, 311:1457–1460.PubMed
31.
go back to reference Carr TP, Parks JS, Rudel LL: Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 1992, 12:1274–1283.PubMed Carr TP, Parks JS, Rudel LL: Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 1992, 12:1274–1283.PubMed
32.
go back to reference Rudel LL, Haines J, Sawyer JK, et al.: Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J Clin Invest 1997, 100:74–83.CrossRefPubMed Rudel LL, Haines J, Sawyer JK, et al.: Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J Clin Invest 1997, 100:74–83.CrossRefPubMed
33.
go back to reference Bell AT III, Wilson MD, Kelley KL, et al.: Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in human apoB-100 transgenic, LDLr -/- mice. J Lipid Res 2007, 48:1122–1131.CrossRefPubMed Bell AT III, Wilson MD, Kelley KL, et al.: Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in human apoB-100 transgenic, LDLr -/- mice. J Lipid Res 2007, 48:1122–1131.CrossRefPubMed
34.
go back to reference Bell AT III, Kelley KL, Wilson MD, et al.: Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in apoB100 only, LDLr-/- mice. Arterioscler Thromb Vasc Biol 2007, 27:1396–1402.CrossRefPubMed Bell AT III, Kelley KL, Wilson MD, et al.: Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in apoB100 only, LDLr-/- mice. Arterioscler Thromb Vasc Biol 2007, 27:1396–1402.CrossRefPubMed
35.••
go back to reference Degirolamo C, Shelness GS, Rudel LL: LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J Lipid Res 2009, 50(Suppl):S434–S439. This review article provides a comprehensive analysis of the current evidence supporting the notion that plasma lipid enrichment with MUFA is predictive for atherosclerosis.CrossRefPubMed Degirolamo C, Shelness GS, Rudel LL: LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J Lipid Res 2009, 50(Suppl):S434–S439. This review article provides a comprehensive analysis of the current evidence supporting the notion that plasma lipid enrichment with MUFA is predictive for atherosclerosis.CrossRefPubMed
36.
go back to reference Rudel LL, Parks JS, Sawyer JK: Compared to dietary monounsaturated and saturated fat, polyunsaturated fat protects African Green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:2101–2110.PubMed Rudel LL, Parks JS, Sawyer JK: Compared to dietary monounsaturated and saturated fat, polyunsaturated fat protects African Green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:2101–2110.PubMed
37.
go back to reference Baylin A, Campos H: The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006, 17:22–27.CrossRefPubMed Baylin A, Campos H: The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006, 17:22–27.CrossRefPubMed
38.
go back to reference Arab L: Biomarkers of fat and fatty acid intake. J Nutr 2003, 133(Suppl 3):925S–932S.PubMed Arab L: Biomarkers of fat and fatty acid intake. J Nutr 2003, 133(Suppl 3):925S–932S.PubMed
39.
go back to reference Laaksonen DE, Nyyssonen K, Niskanen L, et al.: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005, 165:193–199.CrossRefPubMed Laaksonen DE, Nyyssonen K, Niskanen L, et al.: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005, 165:193–199.CrossRefPubMed
40.
go back to reference Harris WS, Poston WC, Haddock CK: Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007, 193:1–10.CrossRefPubMed Harris WS, Poston WC, Haddock CK: Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007, 193:1–10.CrossRefPubMed
41.
go back to reference Harris WS: The Omega-3 Index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep 2009, 11:411–417.CrossRefPubMed Harris WS: The Omega-3 Index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep 2009, 11:411–417.CrossRefPubMed
42.
go back to reference Hodson L, Skeaff CM, Fielding BA: Fatty acid composition of adipose tissue and blood in humans and its use as biomarker of dietary intake. Prog Lipid Res 2008, 47:348–380.CrossRefPubMed Hodson L, Skeaff CM, Fielding BA: Fatty acid composition of adipose tissue and blood in humans and its use as biomarker of dietary intake. Prog Lipid Res 2008, 47:348–380.CrossRefPubMed
43.
go back to reference Covas Mi R-GV, de la Torre R, Kafatos A, et al.: Minor components of olive oil: evidence to date of health benefits in humans. Nutr Rev 2006, 64(Suppl 1):20–30. Covas Mi R-GV, de la Torre R, Kafatos A, et al.: Minor components of olive oil: evidence to date of health benefits in humans. Nutr Rev 2006, 64(Suppl 1):20–30.
44.
go back to reference Cicero AF, Nascetti S, Lòpez-Sabater MC, et al.: Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: the EUROLIVE Study. J Am Coll Nutr 2008, 27:314–320.PubMed Cicero AF, Nascetti S, Lòpez-Sabater MC, et al.: Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: the EUROLIVE Study. J Am Coll Nutr 2008, 27:314–320.PubMed
45.
go back to reference Berglund L, Lefevre M, Ginsberg HN, et al.: Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr 2007, 86:1611–1620.PubMed Berglund L, Lefevre M, Ginsberg HN, et al.: Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr 2007, 86:1611–1620.PubMed
46.
go back to reference Furtado JD, Campos H, Appel LJ, et al.: Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am J Clin Nutr 2008, 87:1623–1630.PubMed Furtado JD, Campos H, Appel LJ, et al.: Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am J Clin Nutr 2008, 87:1623–1630.PubMed
47.
go back to reference Tell GS, Evans GW, Folsom AR, et al.: Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1994, 139:979–989.PubMed Tell GS, Evans GW, Folsom AR, et al.: Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1994, 139:979–989.PubMed
48.
go back to reference Ma J, Folsum AR, Lewis L, Eckfeldt JH.: Relation of plasma phospholipids and cholesterol ester fatty acid composition to carotid artery intima-media thickness in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 1997, 65:551–559.PubMed Ma J, Folsum AR, Lewis L, Eckfeldt JH.: Relation of plasma phospholipids and cholesterol ester fatty acid composition to carotid artery intima-media thickness in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 1997, 65:551–559.PubMed
49.
go back to reference Rohem E: The evidence-based Mediterranean diet reduces coronary heart disease risk, and plant-derived monounsaturated fats may reduce coronary heart disease risk. Am J Clin Nutr 2009, 90:697–698.CrossRef Rohem E: The evidence-based Mediterranean diet reduces coronary heart disease risk, and plant-derived monounsaturated fats may reduce coronary heart disease risk. Am J Clin Nutr 2009, 90:697–698.CrossRef
50.
go back to reference Corella D, Ordovas JM: Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet 2009, 2:637–651.CrossRefPubMed Corella D, Ordovas JM: Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet 2009, 2:637–651.CrossRefPubMed
51.
go back to reference Lefevre M, Champagne CM, Tulley RT, et al.: Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005, 82:957–963.PubMed Lefevre M, Champagne CM, Tulley RT, et al.: Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005, 82:957–963.PubMed
52.
go back to reference Reeves JB III, Weihrauch JL: Composition of Foods: Fats and Oils Raw, Processed, Prepared. Consumer and Food Economics Institute. Agriculture Handbook No. 8–4. USDA Science and Education Administration, Revised June 1979. Washington, DC: US Government Printing Office; 1979. Reeves JB III, Weihrauch JL: Composition of Foods: Fats and Oils Raw, Processed, Prepared. Consumer and Food Economics Institute. Agriculture Handbook No. 8–4. USDA Science and Education Administration, Revised June 1979. Washington, DC: US Government Printing Office; 1979.
Metadata
Title
Dietary Monounsaturated Fatty Acids Appear Not to Provide Cardioprotection
Authors
Chiara Degirolamo
Lawrence L. Rudel
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 6/2010
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-010-0133-4

Other articles of this Issue 6/2010

Current Atherosclerosis Reports 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.